Adnan menderesüniversite Hastanesi
Aydin, Efeler, 09010, Turkey (Türkiye)
NCT Number: NCT07483814
The Importance of Postoperative Analgesia in Shoulder Surgery
Shoulder surgery is an orthopedic procedure that can be performed either through open surgery or arthroscopically. Pain following shoulder surgery can lead to adverse outcomes such as decreased functional status, increased consumption of narcotic analgesics, and the development of chronic pain.
Therefore, achieving optimal postoperative shoulder analgesia is important not only for patient comfort and satisfaction but also for promoting functional recovery, preventing chronic pain, and reducing the need for narcotic analgesics. Additionally, minimizing the side effects associated with nerve block techniques used for analgesia is crucial for the overall success of the treatment.
This study is active but is not currently recruiting participants.
Notify Me18 year–65 year
All sexes
Observational
Aydin, Efeler, 09010, Turkey (Türkiye)
The innervation of the shoulder joint is provided by the axillary, musculocutaneous, subscapular, and suprascapular nerves, all of which originate from the brachial plexus. The suprascapular nerve passes through the suprascapular notch on the superior border of the scapula and supplies motor branches to the rotator cuff muscles. Suprascapular nerve block is widely used in the management of shoulder pain.
Regional anesthesia techniques are among the most effective methods for postoperative analgesia. Peripheral nerve blocks, a subtype of regional anesthesia, are particularly suitable for postoperative pain control in shoulder surgeries due to their ability to provide long-lasting and effective analgesia, reduce opioid requirements and related side effects or dependency, and facilitate recovery by promoting early functional restoration.Interscalene brachial plexus block (ISB) is commonly used for analgesia in shoulder surgery and is considered the gold standard technique. However, ISB also blocks the phrenic nerve (C3-C5), which may result in ipsilateral hemidiaphragmatic paresis (HDP). This can cause respiratory complications, particularly in patients with preexisting pulmonary disease, obstructive sleep apnea, or morbid obesity.
The suprascapular nerve block (SSB), applied at a more distal level of the brachial plexus, preserves the phrenic nerve and thus minimizes the respiratory side effects associated with ISB.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the postoperative recovery room, patients with a Numeric Rating Scale (NRS) score of 4 or higher received 100 mg of intravenous tramadol as rescue analgesia. In addition, both groups routinely received 1 g of intravenous paracetamol every 6 hours during their stay in the ward. During ward follow-up, if the NRS score was 4 or higher, 100 mg of intravenous tramadol was administered as needed.
Time frame: the first 48 hours postoperatively
It is a pain intensity assessment system based on the patient indicating a point between 0 (no pain) and 10 (unbearable pain) to describe their pain level.
Time frame: 3 months postoperatively
Postoperative chronic pain will be evaluated after 3 months using a numerical rating pain scale: 0 (no pain) to 10 (unbearable pain).
Time frame: the first 48 hours postoperatively
The number of patients with dyspnea symptoms after suprascapular and interscalene blocks applied after arthroscopic shoulder surgery will be compared.
Aydin Adnan Menderes University
Other
Comparison of the Analgesic Effects and Side Effects of Interscalene and Suprascapular Blocks for Pain Control Following Arthroscopic Shoulder Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07171125
Lumbar Degenerative Diseases, Neurologic Manifestations
Beijing, China
View Trial DetailsNCT07604376
Neurologic Manifestations, Pain
Târgu Mureş, Mureș County, Romania
View Trial DetailsNCT07126483
Intrathechal Morphine, Neurologic Manifestations
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT07271797
Neurologic Manifestations, Pain
Istanbul, Turkey (Türkiye)
View Trial Details